This guide stays on the lab side of the question. What makes the number move, how a clinician separates noise from a real change, and which results are worth raising promptly.
eGFR stands for estimated glomerular filtration rate, a calculated figure for how much blood the kidneys filter each minute, standardised to body surface area. It is estimated, not measured directly. A lab runs a blood marker, usually creatinine and sometimes cystatin C, then puts that value into an equation along with age and sex.
Typical lab reference ranges sit around 60 to 130 mL/min, and FitScript's optimal range is 90 to 120 mL/min. Reference ranges vary by lab, age and sex, and the optimal range is an optimization target rather than a diagnostic cut-off.
For the full breakdown of what the marker is, how it is tested and how to read a single result, the eGFR guide covers it in detail. Everything below is about one narrower question, what makes the number move from one draw to the next.
Yes, and it happens often enough that a low result is treated as a question rather than an answer. There are two separate reasons a later value can read higher, and they matter in different ways.
The first is that filtration itself recovered. Kidneys can be temporarily stressed, and once the stress passes, filtration returns toward where it was. The second reason, and the more common explanation behind a single surprising result, is that the estimate moved while filtration stayed roughly where it already was.
That second possibility exists because creatinine is a waste product of muscle turnover, not a pure filtration signal. Creatinine levels are affected by factors other than filtration, including muscle mass, diet and the laboratory assay used, so an estimate built from creatinine can shift without any change in the kidneys themselves 1.
Here is the short version of what tends to push an estimate in each direction.
| What changed between draws | Likely direction of the estimated number | Why it moves |
|---|---|---|
| Noticeably dehydrated at the draw | Lower | Less fluid volume concentrates blood and can raise measured creatinine |
| Back to normal fluid intake | Higher | Removes the concentrating effect of the earlier draw |
| Recent acute illness or kidney stress | Lower | Filtration can fall temporarily while the body is under strain |
| Recovery after that episode | Higher | Filtration returns toward its usual level |
| Gained muscle, or trains heavily | Lower | More muscle turnover means more creatinine produced at the same filtration rate |
| Lost muscle, or is less active | Higher | Less creatinine produced, so the equation reads a higher filtration rate |
| Large cooked meat meal shortly before the draw | Lower | Dietary intake adds to the creatinine pool |
| Lab switched equations or assays | Either | The input is the same, the arithmetic is not |
| Cystatin C added to the calculation | Either | A second marker changes which non-filtration factors influence the result |
None of that means a low value should be waved away. It means the number is read in context, and the context is built from a repeat test.
Because one blood draw captures one moment, and the equation behind the number assumes that moment is representative. A repeat draw under ordinary conditions is the cheapest way to find out whether the first reading described the kidneys or described the day.
Confirming an abnormal estimate before acting on it is standard practice in assessing filtration, since a single value carries both biological variation and assay variation inside it 1. Biological variation is the day to day drift in your own creatinine. Assay variation is the small spread you would get if the same sample were run more than once.
There is a second reason, and it is more technical. Creatinine based equations were built on the assumption that creatinine production and clearance are in balance, a state usually described as steady state. When creatinine is actively rising or falling, that assumption breaks. A creatinine based estimate taken while creatinine is not in steady state is associated with substantial error, and can lag well behind what filtration is actually doing at that moment 2.
That is why timing matters so much around an illness. A draw taken on the way down can understate filtration, and a draw taken during recovery can overstate it. The repeat test, taken once things have settled, is the one that gets read as a trend point.
A clinician sets the interval for that repeat based on how low the first value was, what else was happening at the time and what the rest of the panel showed. If the first value was markedly low, that conversation is worth having promptly rather than waiting for a routine recheck.
Enough to matter at the margins, not enough to explain a large unexplained drop on its own. Being noticeably dehydrated at the time of the draw concentrates the blood and can nudge creatinine upward, which the equation reads as lower filtration. Returning to ordinary fluid intake removes that effect at the next test.
The useful framing is that hydration status is one of the conditions surrounding the sample, in the same category as recent illness and recent food. It is a reason to standardise how you turn up for a blood draw, not a lever to pull on a result. Loading up on water immediately before a test to produce a better looking number does not tell you anything you want to know, and it removes the comparability that makes a series of results useful in the first place.
Severe fluid loss is a different situation. When the body is significantly volume depleted, filtration itself can fall, not just the appearance of it. That is a clinical scenario rather than a testing artefact, and it belongs in a conversation with a clinician rather than in a plan to retest next month.
The practical takeaway is simple. Turn up in your normal state, note anything unusual about the days before the draw, and let the pattern across several tests carry the interpretation instead of asking a single number to do it.
Yes, and this is one of the clearest ways an estimate falls and then recovers. During an episode of acute kidney stress, filtration can decline quickly and creatinine climbs behind it. Once the episode resolves, filtration can return toward its previous level and the estimated number rises again.
The complication is that creatinine moves slowly compared with filtration. Research suggests that creatinine based estimating equations perform poorly during acute kidney injury precisely because creatinine is not in steady state, so the calculated number can misrepresent true filtration in both directions while the episode is unfolding 2. Early in the episode the estimate can look better than filtration really is. During recovery it can look worse than filtration really is.
That is why a result drawn around an illness, a hospital stay, a period of poor fluid intake or any acute event is rarely treated as a new baseline. It is treated as a snapshot taken under abnormal conditions, and the baseline is re established afterwards.
For anyone tracking their own panel over time, the practical move is to record the context alongside the number. Was there a fever that week. Was food and fluid intake normal. Was there an unusual physical load. A clinician reading a series of results will ask those questions, and having the answers turns an ambiguous dip into an explainable one. Any acute change in kidney function is a clinician's call, not a self managed one.
Yes, all three can, because creatinine comes from muscle and from meat, not from the kidneys. The equation cannot tell the difference between someone producing more creatinine and someone clearing less of it, so a person with a lot of muscle can read lower than their true filtration, and a person with very little muscle can read higher.
Creatinine has well recognised non filtration determinants, including muscle mass, diet and body composition, which is why a creatinine based estimate is interpreted with the person's build in mind rather than read as a bare number 1. This is the single most common reason a strength trained person is surprised by their result.
A large portion of cooked meat shortly before the draw adds creatinine from the outside. A very hard training session adds muscle turnover. Neither tells you anything about your kidneys, and both are avoidable sources of noise if you standardise the day before a test.
This is also where a second marker earns its place. Research suggests that cystatin C is less influenced by muscle mass than creatinine, which makes it useful when body composition sits at either extreme of the usual range 3. It is not a perfect marker either, and it has its own influences, but it is influenced by different things, which is exactly what makes the pair informative together.
If you lift heavily, carry well above average muscle, or have lost a significant amount of muscle, that context belongs in front of whoever reads your result.
Yes. Two labs can measure identical creatinine and report different estimated filtration rates, because the estimate is arithmetic applied to that measurement, and the arithmetic has been revised over the years.
Equations differ in which variables they include and in how they handle the higher end of the filtration range. A widely used creatinine based equation developed in 2009 was built to improve accuracy compared with the older equation in common use at the time, particularly at higher levels of filtration where the older approach was least reliable 4. That matters for anyone whose numbers sit in the normal to high range rather than near a clinical threshold.
Equation composition has continued to change. Studies indicate that a cystatin C based equation can estimate filtration without including race or sex as variables, which removes inputs that are not biological measurements of the kidney 5.
The practical consequences are worth spelling out. A jump between two results from different labs may be an equation change rather than a biological change. A result that moved after a lab updated its reporting is not a trend point. And comparing a number from several years ago with one from today is only meaningful if you know both were produced the same way.
The fix is unglamorous and effective. Use the same lab where you can, ask which equation and which marker were used, and keep a note of it with the result. If you want to see how different inputs shift the arithmetic, running the numbers through an estimation tool makes the sensitivity obvious very quickly.
Often, yes, and in some situations it changes the interpretation entirely. Cystatin C is a protein filtered by the kidneys that is not produced by muscle, so it sidesteps the biggest confounder in creatinine based estimation.
The strongest option is usually not either marker alone. Research suggests that an equation combining creatinine and cystatin C estimates filtration more accurately than an equation based on either marker on its own 6. When the two markers disagree, that disagreement is itself information, and it prompts a closer look rather than a shrug.
| Approach | What drives the number | Where it is most useful | Main limitation |
|---|---|---|---|
| Creatinine based estimate | Creatinine, age, sex | Routine testing, widely available, inexpensive | Influenced by muscle mass, diet and assay differences |
| Cystatin C based estimate | Cystatin C, age | Very high or very low muscle mass, unclear creatinine results | Less widely ordered, has its own non filtration influences |
| Combined creatinine and cystatin C | Both markers | Confirming a borderline or surprising result | Requires both tests, costs more |
Studies indicate that cystatin C measurement has become more standardised across laboratories over time, which supports its use alongside creatinine rather than purely as a research marker 3.
Whether cystatin C gets added is a clinical decision. It is commonly considered when a creatinine based estimate does not match the person in front of the clinician, when a borderline value needs confirmation before any decision rests on it, or when body composition sits far from average.
A measured GFR shows the filtration rate directly, rather than inferring it from a blood marker. It is done by giving a substance that the kidneys clear in a predictable way, then tracking how fast it disappears from the blood or appears in the urine.
This matters because an estimate is only as good as the relationship between the marker and filtration in that specific person. Measured filtration using an exogenous marker remains the reference approach when an accurate value is needed and an estimate is not trusted, although it is more involved, slower and less widely available than a blood test 7.
Availability is the real constraint. Measured testing takes time, requires a protocol and is not something that fits into a routine panel. Research suggests that dried blood spot sampling may help make measured filtration more practical outside specialist settings by simplifying how samples are collected and handled 8.
For most people, measured GFR never comes up. It becomes relevant when a decision depends on precision, when estimates conflict with each other, or when the estimating equations are known to perform poorly in that person's situation. Deciding whether a measured study is warranted is a clinician's call, and it is not something to request on the strength of one unexpected panel result.
By looking at the direction and persistence of several results rather than the position of one. A single number tells you where the estimate landed on one morning. Three or four results over time, taken under comparable conditions, start to describe a trajectory.
The questions behind that judgement are consistent. Was the low value confirmed on a repeat draw. Were the draws taken at the same lab with the same marker and the same equation. Was anything unusual happening around each draw, such as illness, unusual training, unusual food intake or fluid loss. Does the rest of the picture agree, including urine findings and other blood markers. Does the trend fit the person's age and history.
Markers other than creatinine carry weight here. Assessment of kidney function in practice combines an estimate of filtration with other information rather than resting on a single calculated value, because each individual input has known limitations 1. Urine testing in particular answers a different question from the blood estimate, which is why both commonly appear in the same workup.
The useful mental model is observation, then possible meaning, then next step. The observation is the number and its context. The possible meaning is a range of explanations, from an artefact of the day to a genuine change in filtration. The next step is a repeat test, an additional marker, or a conversation with a clinician, chosen by the clinician rather than by the number alone. No single value, high or low, is a diagnosis.
Yes, and the distinction drives almost everything about how urgently a result is handled. A sudden fall over days or weeks and a gradual decline over years raise different questions and call for different timelines.
A rapid change is harder to quantify from a blood estimate, because the equations assume stability that is not present. During a rapid change, creatinine based estimates can misrepresent true filtration until creatinine settles into a new steady state, which is why these situations are followed with repeated measurements over short intervals rather than a single calculation 2. The pattern of change becomes the signal, not one data point in the middle of it.
A slow drift is a different kind of reading. Filtration tends to decline gradually with age, so a small downward slope across many years is not automatically a sign of disease. What a clinician looks at is whether the slope is steeper than expected for that person, whether it is consistent across markers, and whether anything else on the panel is moving with it.
For someone tracking their own numbers, the practical consequence is this. A sharp unexplained drop is worth discussing with a clinician promptly. A small movement between two tests, within the range of ordinary variation and with no other changes, is usually a reason to keep testing consistently rather than a reason to act. Neither situation is improved by retesting repeatedly in a short window hoping for a better number.
Consistency is the whole technique. The aim is to make each draw resemble the last one closely enough that any difference between them means something.
That means going to the same lab where practical, so the assay and the equation stay fixed. It means turning up in your usual hydration state rather than deliberately over or under hydrated. It means keeping the time of day roughly consistent.
It also means recording what was happening. A note that a draw followed a week of illness, a long flight, a competition or a period of poor appetite is worth more later than the number by itself. Context that is not written down is usually lost by the next test.
And it means not chasing the result. Repeating a test immediately after an unfavourable one, under different conditions, tends to produce confusion rather than clarity. The interval between tests is best set by a clinician in light of what the first result showed.
Filtration is one chapter of kidney assessment, not the whole book, so the estimate is usually read beside other results. Serum creatinine is the raw input behind most estimates, and seeing it alongside the calculated number explains a surprising amount about why the estimate landed where it did.
Cystatin C is the companion marker that answers the muscle mass problem, and combining the two markers estimates filtration more accurately than either alone 6. Urea or BUN adds information about hydration and protein intake. Electrolytes describe the balance the kidneys are maintaining. A urine albumin to creatinine ratio asks a separate question entirely, whether protein is leaking into the urine, and it is not answered by any blood estimate.
Beyond the kidney panel, markers of glucose regulation and blood pressure related measures sit in the same conversation, because long term kidney function is bound up with metabolic and cardiovascular health. Seeing those together over time is more informative than any one marker in isolation.
This is the argument for breadth and repetition in testing rather than one off single marker checks. FitScript's membership is built around 150+ biomarkers tested per year, with results interpreted by Atlas, FitScript's AI health advisor, and any clinical decision made by a licensed provider after reviewing the member.
Whenever it is outside the standard range, whenever it has moved meaningfully from your own baseline, and whenever you are uncertain what it means. A result that is markedly low, or that has fallen sharply since the last test, is worth raising promptly rather than waiting for the next routine panel.
Other situations that deserve a conversation include a value that does not fit the person, such as a low estimate in someone with high muscle mass or a high estimate in someone with very little, a disagreement between creatinine based and cystatin C based results, a result taken during or shortly after an illness, and any low value appearing alongside abnormal urine findings or other out of range kidney markers.
What a clinician does with that information varies. It may be a repeat test, a second marker, urine testing, a review of everything you are currently taking, or a referral. Management decisions belong to a licensed provider who can see the whole picture, including history and medication, none of which appears on a lab report.
This page is educational and is not medical advice. Discuss your results and any next step with a clinician or licensed provider before changing anything.
To see how different inputs change the arithmetic behind a result, the eGFR calculator shows the effect of each variable directly.
It can. A later result may read higher because filtration recovered after a temporary stress, or because the first draw was taken under unusual conditions such as dehydration or illness. Which explanation applies is decided by repeat testing and a clinician's review, not by the single number.
The interval is set by a clinician, based on how low the value was, what was happening around the draw and what the rest of the panel showed. A markedly low value is worth raising promptly rather than waiting for the next routine panel.
Being noticeably dehydrated at the draw can concentrate the blood and push the estimate down, so turning up in your normal hydration state is sensible. Deliberately loading water to produce a better looking number removes the comparability that makes a series of results useful.
Because the number is calculated, not measured. Labs can use different assays and different equations, and equations have been revised over time. Where possible, use the same lab and note which marker and equation produced each result.
It can lower a creatinine based estimate, because creatinine comes from muscle turnover. A person with high muscle mass may produce more creatinine at the same filtration rate, which the equation reads as a lower number. Mention your build to whoever reviews the result.
Keeping conditions consistent helps. A very hard session or a large meat heavy meal shortly before the draw can add creatinine that has nothing to do with the kidneys. Ask your lab about preparation and keep the routine the same for every test.
Cystatin C is a second blood marker used to estimate filtration that is not produced by muscle. It is often considered when a creatinine based result does not fit the person, when body composition sits far from average, or when a borderline value needs confirming. A clinician decides whether to order it.
No. A single value is one snapshot under one set of conditions, and it cannot establish a diagnosis on its own. What it does is prompt a repeat test, possibly a second marker or urine testing, and a conversation with a clinician who can see your full history.
Filtration tends to decline gradually over the years, so a slow downward slope is common. What matters is whether the slope is steeper than expected for that person and whether other kidney markers are moving with it, which is a clinician's judgement.